Looking to publish in Translational Neurodegeneration? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTranslational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. It creates an interface between basic, translational, and clinical research and is affiliated with Ruijin Hospital.
Looking to publish in Translational Neurodegeneration? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Translational Neurodegeneration is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:
Research
Review
Correspondence
Research Highlight
Recent Publications
Persistent PirB cleavage drives Golgi-directed trafficking deficits underlying neurodegeneration
Wu-Bo Han, Xian-Dong Liu, Chang-Fei Tang, Junke Zheng, Tian-Le Xu, Nan-Jie Xu, Suya Sun
From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson’s disease
Zhenwei Yu, Dongning Su, Siming Li, Shinuan Lin, Kang Ren, Tao Feng
Ketogenic diet as a therapeutic strategy for neurodegenerative diseases: from mechanisms to translational challenges
Ana Margarida Salgueiro, Marisa Ferreira-Marques, Rodrigo F. N. Ribeiro, Sara M. Lopes, Dina Pereira, Daniela G. Costa, Magda M. Santana, Luís Pereira de Almeida, Cláudia Cavadas
Mesenchymal stromal cells and neuroinflammation: a multimodal approach to neuroprotection and future therapeutic horizons
Alexandro Angelo Bufi, Andrea Papait, Peter Ponsaerts, Antonietta Rosa Silini, Ornella Parolini
Calbindin-D28k deficiency mediates tau-driven hippocampal hyperexcitement and cognitive impairment
Yang Gao, Xiaoqing Tao, Yuying Wang, Yarong Wang, Huan Li, Yang Yu, Mengqi Tu, Yanchao Liu, Jie Zhou, Yuchen Li, Wei Wei, Xiaochuang Wang, Jie Zheng, Yao Zhang, Haibo Xu, Jian-Zhi Wang
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 11 days.
Reformat to Translational Neurodegeneration using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should explain why the manuscript should be published in Translational Neurodegeneration, address any issues relating to journal policies, declare any potential competing interests, confirm that all authors approved the submission, confirm that the manuscript has not been published or submitted elsewhere, and name the special issue if applicable. Authors may also suggest preferred and non-preferred peer reviewers in the cover letter.
Reformat to Translational Neurodegeneration using Livewrite PremiumWhat are the publication costs?
An article processing charge applies for each accepted article. The current APC is £2290.00 GBP / $3090.00 USD / €2690.00 EUR. The APC for a Research Highlight or Correspondence is £1590.00 GBP / $2180.00 USD / €1890.00 EUR.
Reformat to Translational Neurodegeneration using Livewrite Premium